cell lines
SEngine Precision Medicine, Gustave Roussy to Offer Cancer Drug Sensitivity Testing in Europe
The partners aim to accelerate the implementation of precision oncology in the region, beginning with a clinical trial of colorectal and pancreatic cancer patients.
ROS1 Cancer Model Project Demonstrates Power of Patient Advocacy
The ROS1ders advocacy group is 500 patients strong and they are helping researchers establish cell lines to improve understanding of rare ROS1-positve cancers.